AI assistant
Sending…
Emergent BioSolutions Inc. — Director's Dealing 2023
Jul 24, 2023
32870_dirs_2023-07-24_95240a01-c3c4-4d99-b2ff-b76ae2b6d2fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2023-05-25
Reporting Person: Zoon Kathryn C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-25 | Common Stock | S | 1700 | $8.38 | Disposed | 51801 | Direct |
| 2023-06-02 | Common Stock | S | 1830 | $8.35 | Disposed | 49971 | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Zoon.
More from Emergent BioSolutions Inc.
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Regulatory Filings
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 3